Kopp Convicted on Federal Charges for Murdering Abortion Doctor
Anti-abortion extremist James Kopp was convicted yesterday on federal charges for violating the Freedom of Access to Clinic Entrances (FACE) Act when he shot and murdered an abortion doctor in 1998. Kopp is currently serving a 25-year-to-life sentence on New York state charges for murdering Dr. Barnett Slepian. During his closing statements, Kopp, who is known as "Atomic Dog" in extremist anti-abortion circles, tried to convince the jury that his intention was to only hurt Dr. Slepian, not kill him. The prosecutor countered, saying, "If you want to injure a person, you don't shoot them with a high-powered rifle," the Associated Press reports.
After murdering Dr. Slepian, Kopp fled to Mexico, Ireland, and France, where he was finally captured in 2001. He is suspected in four separate shootings of abortion providers.
According to the AP, prosecutors will ask for a prison term of life without parole. Sentencing is scheduled for July 19, 2007.
10/7/2015 Study Finds US Gender Wage Gap Persists - Data compiled by the US Census Bureau this week once again demonstrates a gender wage gap, showing that American women who work full-time, year-round jobs on average earn 79 cents for every dollar paid to men. . . .
10/6/2015 Australia Deports Anti-Abortion Extremist Troy Newman - Anti-abortion extremist Troy Newman has been deported from Australia after an appeal to remain in the country failed to convince the High Court.
Newman was scheduled to speak at a 10-day Right To Life Australia event, but was detained in Denver, Colorado after Immigration Minister Peter Dutton cancelled his visa citing as grounds for revocation Newman's prior history of promoting violence against abortion providers and their patients. . . .
10/6/2015 Sheryl Sandberg Releases Women In the Workplace Study - Sheryl Sandberg, COO of Facebook and the founder of Lean In has launched Women In The Workplace, a study that looks at the state of women in corporate America.
The study, which was released last week, is an ongoing partnership between Lean In and McKinsey & Company. . . .